Ozempic, Rybelsus, and Victoza are approved only for type 2 diabetes prescribing them for weight loss in non-diabetic patients is legal off-label practice, but insurance coverage for that indication is unlikely
The FDA has also sent warning letters to multiple telehealth companies regarding compounded GLP-1 sales and marketing practices
Losing insurance coverage for your GLP-1 medication doesnt mean the end of your treatment journey
Furthermore, although its very rare, getting too much vitamin B12 can lead to toxicity, says Yuval Pinto, MD, an obesity and family medicine doctor at Johns Hopkins Medicine in Baltimore
These include: Nausea and vomiting (very common, affecting more than 1 in 10 patients) Diarrhoea or constipation Abdominal discomfort or bloating Reduced appetite These symptoms often diminish over several weeks as the body adjusts to the medication
These provide both soluble and insoluble fiber plus water content that aids stool formation